Advisory Board

José Carlos Bouso

March 20, 2022

José Carlos Bouso is a Clinical Psychologist and PhD in Pharmacology. His areas of interest are psychopharmacology and the therapeutic properties of entactogens, psychedelics and cannabis. He has conducted therapeutic research with MDMA, pharmacological research with different substances of both plant and synthetic origin, as well as studies of the long-term neuropsychological effects of substances such as cannabis, ayahuasca and cocaine. He is the author of the book “What are synthetic drugs”, and co-author of “Marijuana as a medicine?

More information

Francisco Azorín

March 19, 2022

Expert in the defense of cannabis growers, industrial hemp, other psychoactive plants as well as drug trafficking in general. Director of Brotsanbert Yecla Law Firm. Co-author in the writing of three scientific books, many articles in magazines of the cannabis sector as well as several academic articles in publishers such as the Revista Española de Drogodependencias or Cannabis Reserach Institute. Member of the European Observatory of Cannabis Consumption and Cultivation where he published the collective work Self-farming and use of cannabis in Spain, with a foreword by Antonio Escohotado as well as the first work of his own direction: Cannabis, Science and Law, where the great mysteries and the biggest inconsistencies of the legislation and jurisprudence on drugs are explained and which has been prefaced by Mr.

More information

Antón Gómez-Escolar

March 18, 2022

Scientific analyst specialized in psychedelics, nootropics and other psychoactive drugs. Master on Psychopharmacology and Illicit Drugs at Madrid Complutense University. Works as a scientific advisor, researcher, international presenter, columnist at “Hemp Magazine”, and with information, harm reduction, drug checking and psychedelic emergency tripsitting NGOs & programs, like Energy Control (ABD). Co-founder of Madrid’s Psychedelic Society. Member of the European psychedelic science association MIND. Member of the Commission on International Drug Policy of the UNAD network.

More information